Oral Contraceptives and Increased Formation of Soluble Fibrin
- 31 August 1974
- Vol. 3 (5930), 556-558
- https://doi.org/10.1136/bmj.3.5930.556
Abstract
Soluble fibrin was measured weekly for two months in 12 normal women and in 12 women on combined oestrogen-progestogen therapy (Ortho-Novin, Norinyl, Enavid, Ovral, Ovulen, Demulen). Plasma soluble fibrin concentration in women on oral contraceptives showed an increase of 97·2% (P <0·001) above that of normal women. In three cases, where each woman on the oral contraceptive served as her own control, stopping medication led to a return to normal of the plasma content of soluble fibrin.Keywords
This publication has 10 references indexed in Scilit:
- Evidence for Abnormalities in Clotting and Thrombolysis as a Risk Factor For StrokeStroke, 1973
- Detection of intravascular coagulationJournal of Clinical Investigation, 1971
- Measurement of spontaneous fibrinolytic activityJournal of Clinical Pathology, 1964
- Blood Coagulability and Oral ContraceptionBMJ, 1964
- Evidence for Steroid Control of the Metabolism of ProfibrinolysinThrombosis and Haemostasis, 1964
- The Partial Thromboplastin Time with Kaolin: A Simple Screening Test for First Stage Plasma Clotting Factor DeficienciesAmerican Journal of Clinical Pathology, 1961
- Relation of plasma fibrinogen concentration changes to human arteriosclerosisJournal of Applied Physiology, 1961
- Thromboembolic Complications during and after Cortisone and Acth TherapyPublished by Oxford University Press (OUP) ,1956
- Antagonistic Effect of A.C.T.H. and Cortisone on the Anticoagulant Activity of Ethyl BiscoumacetateBMJ, 1954
- [Indications and contraindications for anticoagulant therapy in the light of coagulation physiology].1954